WASHINGTON (AP) — The Food and Drug Administration is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or effective for common age-related issues like low libido and fatigue. The agency says drugmakers must clearly state in their labeling and promotions that the drugs, currently taken by millions of U.S.
Topics: low-t. washington ap the food drug administration health canada eli lilly co dr sidney wolfe public citizen february roughly abbvie's androgel north chicago-based abbvie testosterone additionally january companies androgel endo pharmaceuticals aveed the the u.s fda july the fda abbvie abbvie's androgel lilly's axiron men warning levels heart problems prescription patients common issues variety established drugmakers safety labeling injections risks statement approved sexual aging caused millions risk advertising stroke attack studies
BING NEWS:
- People’s Pharmacy: FDA won’t put drug advertising genie back in a bottle
No one should ever stop using a beta blocker suddenly! Discontinuation could lead to serious heart complications. Some people may need to continue taking a beta blocker like metoprolol despite skin or ...
04/15/2024 - 10:40 am | View Link - Hundreds of drugs are in short supply around the U.S., pharmacists warn
In the first three months of the year, there were 323 active medication shortages, surpassing the previous high of 320 shortages in 2014, according to a survey by the American Society of Health-System ...
04/12/2024 - 12:49 pm | View Link - FDA head calls on Congress to pass mandatory testing for lead in food
The FDA commissioner urged Congress on Thursday to pass legislation mandating that food manufacturers test for lead in products imported to the United States.
04/11/2024 - 4:14 pm | View Link - Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes
Functional precision medicine works to take the guesswork out of deciding which drug to try next for patients with cancers that don’t respond to standard treatments.
04/10/2024 - 11:00 pm | View Link - Fast-tracked cancer drugs often fail to prove benefit
Less than half of cancer drugs given accelerated approval showed clinical benefit at least five years later, a JAMA study finds.
04/7/2024 - 10:40 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more